Active Ingredient(s):Rituximab-pvvr FDA Approved: * July 23, 2019 Pharm Company: *PFIZER INC Category:Cancer
Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in non-geriatric patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-positive mucocutaneous ulcers.[10&...
* May have multiple approval dates, manufacturers, or labelers.